| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 32.993 | 33.808 | 35.669 | 42.633 | 52.076 | 56.018 | 55.002 | 60.817 | 93.876 | 96.289 |
| Total Income - EUR | 36.232 | 33.808 | 35.670 | 42.634 | 52.077 | 56.019 | 57.025 | 60.818 | 93.877 | 96.291 |
| Total Expenses - EUR | 10.261 | 8.406 | 9.688 | 15.726 | 12.951 | 13.477 | 15.127 | 15.670 | 15.381 | 17.163 |
| Gross Profit/Loss - EUR | 25.971 | 25.402 | 25.982 | 26.908 | 39.125 | 42.542 | 41.898 | 45.148 | 78.496 | 79.128 |
| Net Profit/Loss - EUR | 24.884 | 24.699 | 25.625 | 26.482 | 38.605 | 41.991 | 41.348 | 44.539 | 77.558 | 76.239 |
| Employees | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Fraluc Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.571 | 5.035 | 4.729 | 4.426 | 4.128 | 3.842 | 3.705 | 4.572 | 5.074 | 5.423 |
| Current Assets | 21.298 | 20.386 | 21.535 | 23.236 | 35.352 | 39.152 | 38.675 | 41.510 | 73.887 | 75.734 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 466 | 465 | 462 |
| Receivables | 1.878 | 1.470 | 2.866 | 3.353 | 4.516 | 5.421 | 4.518 | 33.208 | 12.437 | 38.416 |
| Cash | 19.419 | 18.916 | 18.669 | 19.884 | 30.836 | 33.731 | 34.157 | 7.836 | 60.985 | 36.856 |
| Shareholders Funds | 24.938 | 24.752 | 25.678 | 26.534 | 38.656 | 42.041 | 41.396 | 44.588 | 77.606 | 76.287 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 931 | 669 | 586 | 1.129 | 824 | 953 | 984 | 1.494 | 1.356 | 4.870 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Fraluc Med Srl